ReNeuromed at INS2024: Co-Shaping the Future of Global Neuromodulation

May 21, 2024 19:21 CST Updated 19:21

Rishena Medical

Implantable Medical Device R&D and Production Manufacturer

May 11-16, lasting 6 daysThe 16th World Congress of the International Neuromodulation Society (INS2024)Successfully concluded in Vancouver, Canada.

The theme of this conference is "Neuromodulation: Harnessing the Power of the Nervous System", a theme that emphasizes the transformative power of neuromodulation in disease treatment and the experiential therapies offered through precise and personalized techniques.

INS2024 Opening Ceremony

Rishena Medical, a leading company in China's neuromodulation field, was invited to participate in this grand event. It showcased its full range of self-developed products to domestic and international attendees, including Vagus Nerve Stimulator (VNS), Single-Use Intracranial Electrodes (SEEG), Rechargeable Spinal Cord Stimulator (SCS), Implantable Closed-Loop Neurostimulator (CNS), and Transcutaneous Vagus Nerve Stimulator (tVNS).

For many years, Rishena Medical has been rooted in China, focusing on key areas of brain science research. Multiple products have been approved and launched in the Chinese market, providing comprehensive solutions for disease treatment and receiving consistent praise from doctors and patients. At the same time, the company is actively expanding into international markets, responding positively to the national "Belt and Road" initiative, and accelerating its "going global" strategy. It has successfully conducted VNS, SCS, and SEEG surgeries in several countries, competing on the same stage as similar enterprises worldwide, and contributing the strength of a Chinese brand.

At INS2024, Rishena Medical attracted significant attention from attendees and further enhanced its influence and reputation in the international market. Moving forward, Rishena Medical will continue to uphold the principles of meticulousness, high quality, and efficiency, working with global partners to advance the field of neuromodulation.

About Rishena Medical

Rishena Medical Co., Ltd. is an innovative high-tech enterprise focusing on the research, development, production, and sales of active implantable medical devices.

The company originated from the industrial-academic transformation of an implantable neural stimulator project by a team from Tsinghua University's Microelectronics Institute. It settled in 2013 in the national-level development zone in Changzhou, Jiangsu Province. The founding team graduated from Tsinghua University and was co-founded with the participation of Tsinghua Venture Capital and listed companies.

The company has a high-level R&D, production, quality control, clinical and marketing team, owns more than 100 patents, and has received support from national key R&D projects, the Brain Project, provincial innovation and entrepreneurship teams, among other government initiatives. It was also successfully selected as one of "Jiangsu Province's Potential Unicorn Enterprises in 2023."

For many years, Rishena Medical has been actively involved in key areas of brain science research, providing comprehensive solutions for disease treatment. The company’s self-developed products, including the implantable vagus nerve stimulator (VNS), single-use intracranial electroencephalogram electrodes (SEEG), rechargeable implantable spinal cord stimulator (SCS), and transcutaneous auricular vagus nerve stimulator (t-VNS), have been approved and launched in the market. The implantable closed-loop neural stimulator (CNS) is about to be launched, and the intrathecal drug delivery system (IDDS) is awaiting entry into the clinical trial phase. In the future, more innovative products that address unmet clinical needs will be introduced.

Rishena Medical always adheres to the quality policy of "Valuing quality is caring for life," placing product quality as the top priority, constantly refining product quality, with the goal of becoming China's most outstanding active implantable medical device enterprise.

Statement: The intellectual property rights of the content published by Neuromedical Hub, including Neurosurgery Information, Neurointervention Information, Neuromedical Consultation, and AiBrain, belong to Neuromedical Hub, the organizers, original authors, and other relevant right holders. Without permission, reproduction, excerpting, copying, cropping, recording, etc., are prohibited. Even with authorized use, the source must be cited. Forwarding and sharing are welcome.

For submission/conference release, please contact 400-888-2526 ext. 3

BrainMed HubApp (OriginalNeurosurgery Information/Neurointerventional InformationApp）“"Topic Circle"重磅上线! Here you will find various professional questions and authoritative answers. Click "Read the Original Text"Exclusive Preview!"

Share

Favorite

Like

Tap to view